Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

H5N1 virus mutating in humans, study finds
The human strain of H5N1 caused a more severe disease than the bovine strain.
Research found nine additional mutations in the human strain.

A study into the spread of H5N1 in the United States of America has revealed that the virus has developed new mutations in human hosts.

Researchers from Texas Biomedical Research Institute (Texas Biomed) identified nine additional mutations in the human strain of H5N1 compared to the strain present in bovines.

H5N1, commonly known as bird flu, is naturally found in wild birds and is lethal in chickens. It has since spread through a variety of mammals, first being identified in dairy cows in spring 2024.

The first reported death caused by H5N1 was reported in January 2025, as a result of exposure to infected chickens.

Researchers are increasingly concerned about the evolution of the virus, particularly of its potential to transmit from human to human. Texas Biomed has been studying H5N1 since the outbreak began last year, using specialised tools and animal models.

When comparing the human strain of H5N1 to the strain in bovines, researchers identified nine additional mutations which were believed to have occurred after human infection.

The study found that the human strain of H5N1 caused a more severe disease than the bovine strain. The human strain also replicated more efficiently and was found in much higher quantities in brain tissue.

However, the researchers did also identify that the mutations were not affecting the efficacy of approved antibiotics.

The researchers say that this is an important finding, as antibiotics will be vital if a pandemic does occur. Humans have no pre-existing immunity against H5N1, and seasonal flu vaccines offer limited protection.

Future research will see the team explore the human strain individually, investigating why infections from cows appear to be less harmful than from chickens. They will also examine why H5N1 causes mild disease in cows, but is lethal in cats.

Ahmed Mostafa Elsayed, staff scientist at Texas Biomed, said: "A key priority will be to eradicate bird flu from dairy cows to minimize risk of mutations and transmission to people and other species,

"Steps that can be taken now include thorough decontamination of milking equipment and more stringent quarantine requirements, which will help eliminate the virus more quickly in cows."

The full study can be found in the journal Emerging Microbes and Infections.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

VMD responds to Solensia injection concerns

News Story 1
 The VMD has added anaphylaxis to the SPC of Solensia 7 mg/ml Solution for Injection for Cats.

It says that this is a rare side effect, with such adverse events affecting fewer than three animals for every 1000 doses of Solensia sold.

Solensia is used to alleviate osteoarthritis pain in cats. It contains the active ingredient frunevetmab.

Anaphylaxis joins effects such as alopecia, dermatitis, pruritus on the list of adverse effects.

The VMD says that is constantly reviewing adverse event data for all medicines. 

Click here for more...
News Shorts
Applications open for RCVS Fellowship

The Royal College of Veterinary Surgeons (RCVS) has opened applications for veterinary surgeons to join the RCVS Fellowship.

The RCVS Fellowship is a learned society which works to advance veterinary standards and promote scientific excellence.

Veterinary surgeons can enter the RCVS Fellowship through three routes, each with different criteria. This enables people with a range of expertise and experience to join the society.

The routes are: Meritorious Contributions to Clinical Practice, Meritorious Contributions to Knowledge and Meritorious Contributions to the Profession.

Applicants must share a summary of their contributions to the profession, including examples of significant works produced throughout their career. The application will then be assessed by a panel of judges against a set of criteria.

Veterinary surgeons have until 4pm on Friday, 14 March to submit applications. More information, including requirements and guidance can be found here.